XML 159 R143.htm IDEA: XBRL DOCUMENT v3.25.1
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION - Condensed balance sheets (Details)
¥ in Thousands, $ in Thousands
Dec. 31, 2024
CNY (¥)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
CNY (¥)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
CNY (¥)
Dec. 31, 2021
CNY (¥)
Current assets:            
Cash and cash equivalent ¥ 216,224 $ 29,623 ¥ 58,139      
Prepayments and other current assets 527,760 72,303 412,946      
Total current assets 983,972 134,804 617,208      
Total assets 6,726,388 921,512 6,053,943      
Current liabilities:            
Long-term, current portion 383,016 52,473 722,563      
Accrued expenses and other liabilities (including loan from related party of RMB1,861 and RMB1,937 (US$265) as of December 31, 2023 and 2024, respectively) 846,194 115,928 731,793      
Derivative liability 0   163      
Other payables 136,706 18,729 171,127      
Total current liabilities 2,125,355 291,172 1,951,394      
Non-current liabilities:            
Long-term bank and other borrowings, non-current portion 2,693,693 369,034 1,994,014      
Total liabilities 5,108,639 699,879 4,306,956      
Shareholders' equity (deficit):            
Treasury stock (12,101,847 and 12,101,847 shares as of December 31, 2023 and 2024, respectively) (7) (1) (7)      
Additional paid-in capital 2,169,693 297,247 2,007,965      
Accumulated other comprehensive loss (77,349) (10,596) (65,419)      
Accumulated deficit (4,372,832) (599,076) (4,064,589)      
Total Concord Medical Services Holdings Limited shareholders' deficit (2,280,390) (312,411) (2,121,945)      
Total liabilities and equity 6,726,388 921,512 6,053,943      
Common Class A            
Shareholders' equity (deficit):            
Ordinary shares 68 10 68      
Common Class B            
Shareholders' equity (deficit):            
Ordinary shares 37 5 37      
Related party            
Current assets:            
Amounts due to subsidiaries 120,391 16,494 151,685      
Current liabilities:            
Accrued expenses and other liabilities (including loan from related party of RMB1,861 and RMB1,937 (US$265) as of December 31, 2023 and 2024, respectively) 1,937 265 1,861      
Other payables 117,630 16,115 9,671      
Non-current liabilities:            
Long-term bank and other borrowings, non-current portion 95,493 13,082 69,182      
Subsidiaries            
Current assets:            
Amounts due to subsidiaries 195,225 26,746 185,466      
Parent Company            
Current assets:            
Cash and cash equivalent 409 56 17,466 $ 2,393 ¥ 1,510 ¥ 15,058
Prepayments and other current assets 73,592 10,082 24,999      
Total current assets 74,001 10,138 42,465      
Total assets 74,001 10,138 42,465      
Current liabilities:            
Short term loan 34,307 4,700 41,179      
Long-term, current portion 84,482 11,574 110,574      
Accrued expenses and other liabilities (including loan from related party of RMB1,861 and RMB1,937 (US$265) as of December 31, 2023 and 2024, respectively) 67,300 9,220 20,483      
Derivative liability     163      
Total current liabilities 2,524,075 345,795 2,164,410      
Non-current liabilities:            
Long-term bank and other borrowings, non-current portion 2,190 300        
Total liabilities 2,526,265 346,095 2,164,410      
Shareholders' equity (deficit):            
Treasury stock (12,101,847 and 12,101,847 shares as of December 31, 2023 and 2024, respectively) (7) (1) (7)      
Additional paid-in capital 2,169,693 297,247 2,007,965      
Accumulated other comprehensive loss (77,349) (10,596) (65,419)      
Accumulated deficit (4,544,706) (622,622) (4,064,589)      
Total Concord Medical Services Holdings Limited shareholders' deficit (2,452,264) (335,957) (2,121,945)      
Total liabilities and equity 74,001 10,138 42,465      
Parent Company | Common Class A            
Shareholders' equity (deficit):            
Ordinary shares 68 10 68      
Parent Company | Common Class B            
Shareholders' equity (deficit):            
Ordinary shares 37 5 37      
Parent Company | Subsidiaries            
Current assets:            
Amounts due to subsidiaries ¥ 2,337,986 $ 320,301 ¥ 1,992,011